Product Name | NebuSelect™ Recombinant Human CA9/Carbonic Anhydrase IX, Avi-His-tag |
---|---|
Catalog Number | NBL-240895 |
Alias/Synonyms | CA9/Carbonic Anhydrase IX; CA9; CAIX; CA-IX; EC 4.2.1.1; G250; MN; P54/58N; PMW1; RCC |
Appearance | see COA |
Molecule Weight | Gln38-Asp414 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q16790 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240895-100ug | 100ug | Inquire | Inquire | |
NBL-240895-1mg | 1mg | Inquire | Inquire | |
NBL-240895-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CA9/Carbonic Anhydrase IX, Avi-His-tag
Catalog#:
NBL-240895
Description:
NebuSelect™ Recombinant Human CA9/Carbonic Anhydrase IX, Avi-His-tag(Cat#NBL-240895) is expressed in HEK293 with His tag and Avi tag at the C-Terminus; It contains Gln38-Asp414.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 43.7 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
CA9/Carbonic Anhydrase IX; CA9; CAIX; CA-IX; EC 4.2.1.1; G250; MN; P54/58N; PMW1; RCC
Target Information:
CA9 is a member of the carbonic anhydrases' family, that is often expressed in cancer cells under hypoxic condition. CA9 expression potentially contributes to the regulation of cancer cell differentiation and mediates tumour-associated genes and signalling pathways, including apoptosis, hypoxia, G2M checkpoint, PI3K/AKR/mTOR signalling and TGF-beta signalling pathways.
Amino Acid Sequence:
Gln38-Asp414
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.